Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy’s Laboratories, is a global CRO/CDMO headquartered in India with operations supporting discovery, development, and manufacturing for small and large molecule therapeutics. The company offers customized synthesis of mRNA for preclinical studies, in vitro transcription, purification, and analytical support for therapeutics, diagnostics, and vaccines. Its capabilities also include biologics and biosimilars development, monoclonal antibody and protein therapeutics, bioanalytical and physiochemical characterization, and GMP manufacturing of complex drug products.